Incidensen af disse hændelser var imidlertid højere hos patienter, der fik etoricoxib sammenlignet med dem, der fik naproxen 500 mg 2 gange dagligt.
However, the rate of these events was higher in patients receiving etoricoxib compared with those receiving naproxen 500 mg twice daily.